SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Journal of Intensive Care Medicine
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Debellis, R. J.
Right arrow Articles by Volturo, G. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Debellis, R. J.
Right arrow Articles by Volturo, G. A.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Antibiotics
*Antidepressants
Hazardous Substances DB
*CITALOPRAM HYDROBROMIDE
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Linezolid-Associated Serotonin Syndrome After Concomitant Treatment With Citalopram and Mirtazepine in a Critically Ill Bone Marrow Transplant Recipient

Ronald J. Debellis, PharmD, FCCP

Massachusetts College of Pharmacy and Health Sciences-Worcester, Worcester, MA, Department of Pulmonary, Allergy and Critical Care Medicine, rjdebellis{at}wor.mcphs.edu

Oren P. Schaefer, MD, FCCP

Department of Pulmonary, Allergy and Critical Care Medicine

Michelina Liquori

Massachusetts College of Pharmacy and Health Sciences-Worcester, Worcester, MA

Gregory A. Volturo, MD, FACEP

Department of Emergency Medicine, University of Massachusetts Medical School, Worcester, MA

Linezolid was initially discovered as an antidepressant because of its effect on blocking intracellular metabolism of serotonin, norepinephrine, and other biogenic amines. As time passed, it was realized that linezolid possessed antibacterial activity, and linezolid has been developed and marketed as such. In medicine we are quick to categorize drugs into specific classes as a mechanism to recall indication and use. By classifying linezolid as an antibacterial, it is common to forget about its antidepressant roots. A case report involving linezolid with citalopram and mirtazepine in the precipitation of serotonin syndrome in a critically ill bone marrow transplant patient is described in this article.

Key Words: linezolid • citalopram • mirtazepine • serotonin syndrome • SSRI • antidepressant • antibiotic

Journal of Intensive Care Medicine, Vol. 20, No. 6, 303-305 (2005)
DOI: 10.1177/0885066605280825


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




Advertisement